Blacktrace Holdings Acquires ChemiSens AB Assets
News Feb 20, 2015
Blacktrace Holdings Limited has announced that with effect from 16th January 2015 it has acquired the assets of ChemiSens AB, based in Lund, Sweden. ChemiSens has a 30-year proven track record in the development, manufacture and supply of the highest performance reaction calorimeters.
These sophisticated systems, which will now be supplied and supported via the Syrris brand, perfectly complement the Syrris product range.
Reaction calorimeters are used in a wide range of applications, including carbon capture and sequestration, biological performance, and chemical reaction kinetic and scale-up safety studies.
The combined Syrris and ChemiSens product portfolio - from the straightforward, easy-to-use Atlas Calorimeter to the high performance CPA200 series - allows Syrris to meet customers’ differing needs and applications, whether an introductory or top-end calorimeter is required.
And, with the company’s global presence and the knowledgeable Syrris support team, new and existing customers can be assured of continued worldwide access to professional advice.
Blacktrace is looking forward to working with existing ChemiSens partners, and intends to keep the current structure for the foreseeable future.
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018